Skip to main content
INSM logo

Insmed Incorporated

INSMNASDAQHealthcareBiotechnology

$93.33Today:- (-)1Y −40.63%

As of Oct 26, 2026 close

Market cap
$20.29B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$90.39$212.75
Volume (live)
-
Avg. volume (3M)
2.81M

Insmed Incorporated (INSM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Insmed Incorporated stock.

Analyst Consensus Rating

Investment consensus from 24 professional research analysts

Consensus Rating

Buy
Based on 24 unique analysts
(39 total ratings in last 90 days)
Very High Confidence10.5:1 Buy/Sell

Average Price Target

$196.16
+106.57% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest INSM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Maxwell Skor
Morgan Stanley
BuyReiterates
$218.00 → $213.00
Adam Walsh
Roth MKM
BuyReiterates
$198.00
Tiago Fauth
Raymond James
BuyMaintains
$187.00 → $173.00
Benjamin Burnett
Wells Fargo
BuyReiterates
$169.00
Andrew Fein
HC Wainwright
BuyMaintains
$220.00
Jason Zemansky
BofA Securities
BuyReiterates
$207.00
Conor MacKay
BMO Capital
BuyMaintains
$192.00
Andy Chen
Wolfe Research
HoldDowngrades
-
Leonid Timashev
RBC Capital
BuyMaintains
$195.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$218.00
Ashwani Verma
UBS
BuyMaintains
$172.00
Leonid Timashev
RBC Capital
BuyMaintains
$195.00
Ashwani Verma
UBS
BuyMaintains
$172.00
Conor MacKay
BMO Capital
BuyMaintains
$192.00
Graig Suvannavejh
Mizuho
BuyMaintains
$195.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$218.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$218.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
Eliana Merle
Barclays
BuyMaintains
$237.00 → $207.00
Jessica Fye
JP Morgan
BuyReiterates
$175.00
Andrea Newkirk
Goldman Sachs
BuyInitiates
$188.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Graig Suvannavejh
Mizuho
BuyMaintains
$195.00
Jason Zemansky
BofA Securities
BuyMaintains
$214.00
Jason Zemansky
BofA Securities
BuyMaintains
$214.00
Adam Walsh
Roth MKM
BuyReiterates
$212.00 → $198.00
Ekta Bagri
Zacks Equity Research
SellInitiates Coverage
-
Leonid Timashev
RBC Capital
BuyMaintains
$195.00
Conor MacKay
BMO Capital
BuyMaintains
$192.00
Andrew Fein
HC Wainwright
BuyMaintains
$220.00
Danielle Brill
Truist
BuyReiterates
$185.00 → $195.00
Ashwani Verma
UBS
BuyMaintains
$166.00 → $172.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$160.00 → $170.00
Vamil Divan
Guggenheim
BuyReiterates
$207.00 → $205.00
Olivia Brayer
Cantor Fitzgerald
BuyMaintains
$235.00
Matt Phipps
William Blair
BuyMaintains
-
Faisal Khurshid
Jefferies
BuyMaintains
$160.00 → $175.00
Ritu Baral
TD Cowen
BuyMaintains
$243.00
Benjamin Burnett
Wells Fargo
BuyMaintains
$161.00 → $169.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for INSM?

The analyst consensus rating for INSM is Buy, based on the latest ratings from 24 analysts over the last 90 days.

What is the average price target for INSM?

The average 12-month price target for INSM is $196.16, representing an upside of 106.6% from the Oct 27, 2026 close of $94.96.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.